GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
GB1528382A
(en)
|
1974-12-26 |
1978-10-11 |
Teijin Ltd |
Cyclopentene diols and acyl esters thereof and processes for their preparation
|
JPS5481295A
(en)
*
|
1977-12-13 |
1979-06-28 |
Suami T |
Adenosin analogue compounds
|
FR2459240A1
(fr)
|
1979-06-21 |
1981-01-09 |
Cm Ind |
Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent
|
EP0147716A3
(de)
|
1983-12-24 |
1987-10-28 |
ANT Nachrichtentechnik GmbH |
Verfahren und Anordnung zur verschlüsselbaren Übertragung einer Nachrichten-Binärzeichenfolge mit Authentizitätsprüfung
|
JPS6235216A
(ja)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
不均質物質層の層厚非破壊測定方法および装置
|
US4738954A
(en)
|
1985-11-06 |
1988-04-19 |
Warner-Lambert Company |
Novel N6 -substituted-5'-oxidized adenosine analogs
|
US4873360A
(en)
|
1986-07-10 |
1989-10-10 |
Board Of Governors Of Wayne State University |
Process for the preparation of cyclopentanoids and novel intermediates produced thereby
|
IL84414A0
(en)
|
1986-11-14 |
1988-04-29 |
Ciba Geigy Ag |
N9-cyclopentyl-substituted adenine derivatives
|
US4954504A
(en)
|
1986-11-14 |
1990-09-04 |
Ciba-Geigy Corporation |
N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
|
JP2586897B2
(ja)
|
1987-03-09 |
1997-03-05 |
富士薬品工業株式会社 |
光学活性なシス−シクロペンテン−3,5−ジオ−ルモノエステルの製造法
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
ATE147074T1
(de)
|
1990-09-25 |
1997-01-15 |
Rhone Poulenc Rorer Int |
Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
US5451700A
(en)
|
1991-06-11 |
1995-09-19 |
Ciba-Geigy Corporation |
Amidino compounds, their manufacture and methods of treatment
|
WO1993018007A1
(en)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Novel carbostyril derivative
|
US5605923A
(en)
|
1992-04-02 |
1997-02-25 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
US5552438A
(en)
|
1992-04-02 |
1996-09-03 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
WO1993019750A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic or inflammatory diseases
|
IT1254915B
(it)
|
1992-04-24 |
1995-10-11 |
Gloria Cristalli |
Derivati di adenosina ad attivita' a2 agonista
|
US5688774A
(en)
|
1993-07-13 |
1997-11-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
A3 adenosine receptor agonists
|
US5691188A
(en)
|
1994-02-14 |
1997-11-25 |
American Cyanamid Company |
Transformed yeast cells expressing heterologous G-protein coupled receptor
|
US6143749A
(en)
*
|
1995-06-07 |
2000-11-07 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
WO1997024327A1
(en)
|
1996-01-02 |
1997-07-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine
|
US6376472B1
(en)
|
1996-07-08 |
2002-04-23 |
Aventis Pharmaceuticals, Inc. |
Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
US6211165B1
(en)
|
1997-05-09 |
2001-04-03 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
FR2780057B1
(fr)
|
1998-06-18 |
2002-09-13 |
Sanofi Sa |
Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
|
SK19542000A3
(sk)
|
1998-06-23 |
2001-09-11 |
Glaxo Group Limited |
2-(purin-9-yl)-tetrahydrofurn-3,4-diolov derivty, spsob ich vroby, farmaceutick prostriedok s ich obsahom, ich pouitie a medziprodukty
|
GB9813535D0
(en)
*
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813540D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813554D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
BR9815931A
(pt)
|
1998-06-30 |
2001-02-20 |
Dow Chemical Co |
Polióis poliméricos, um processo para sua produção, e espuma de poliuretanoobtida
|
ATE331726T1
(de)
|
1998-10-16 |
2006-07-15 |
Pfizer |
Adenine-derivate
|
AU2187100A
(en)
|
1998-12-31 |
2000-07-24 |
Aventis Pharmaceuticals Products Inc. |
Process for preparing n6-substituted deaza-adenosine derivatives
|
US7214665B2
(en)
|
2001-10-01 |
2007-05-08 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
|
US7427606B2
(en)
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
HUP0203528A3
(en)
|
1999-05-04 |
2003-11-28 |
Schering Corp |
Piperidine derivatives useful as ccr5 antagonists, pharmaceutical compositions containing them and their use
|
KR100439358B1
(ko)
|
1999-05-04 |
2004-07-07 |
쉐링 코포레이션 |
Ccr5 길항제로서 유용한 피페라진 유도체
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
US6403567B1
(en)
|
1999-06-22 |
2002-06-11 |
Cv Therapeutics, Inc. |
N-pyrazole A2A adenosine receptor agonists
|
US6214807B1
(en)
|
1999-06-22 |
2001-04-10 |
Cv Therapeutics, Inc. |
C-pyrazole 2A A receptor agonists
|
AU778450B2
(en)
*
|
1999-07-02 |
2004-12-09 |
Eisai R&D Management Co., Ltd. |
Fused imidazole compounds and remedies for diabetes mellitus
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
EA006685B1
(ru)
|
1999-08-21 |
2006-02-24 |
Алтана Фарма Аг |
Синергетическая композиция
|
US6586413B2
(en)
|
1999-11-05 |
2003-07-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
GB0003960D0
(en)
|
2000-02-18 |
2000-04-12 |
Pfizer Ltd |
Purine derivatives
|
HUP0300832A2
(hu)
|
2000-04-27 |
2003-08-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
|
TWI227240B
(en)
*
|
2000-06-06 |
2005-02-01 |
Pfizer |
2-aminocarbonyl-9H-purine derivatives
|
ES2213703T5
(es)
|
2000-06-27 |
2011-11-02 |
Laboratorios S.A.L.V.A.T., S.A. |
Carbamatos derivados de arilalquilaminas.
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
WO2002012265A1
(en)
|
2000-08-05 |
2002-02-14 |
Glaxo Group Limited |
6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
|
GB0022695D0
(en)
|
2000-09-15 |
2000-11-01 |
Pfizer Ltd |
Purine Derivatives
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
EP1345937B1
(en)
|
2000-12-22 |
2005-09-28 |
Almirall Prodesfarma AG |
Quinuclidine carbamate derivatives and their use as m3 antagonists
|
ES2266291T3
(es)
|
2000-12-28 |
2007-03-01 |
Almirall Prodesfarma Ag |
Nuevos derivados de quinuclidina y composiciones medicinales que los contienen.
|
ATE292973T1
(de)
|
2001-01-16 |
2005-04-15 |
Can Fite Biopharma Ltd |
Verwendung eines adenosin-a3-rezeptor-agonisten zur hemmung der virenreplikation
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
GB2372741A
(en)
|
2001-03-03 |
2002-09-04 |
Univ Leiden |
C2,8-Disubstituted adenosine derivatives and their different uses
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
US20040162422A1
(en)
*
|
2001-03-20 |
2004-08-19 |
Adrian Hall |
Chemical compounds
|
ATE381537T1
(de)
|
2001-03-22 |
2008-01-15 |
Glaxo Group Ltd |
Formanilid-derivative als beta2-adrenorezeptor- agonisten
|
SI1383786T1
(sl)
|
2001-04-30 |
2009-02-28 |
Glaxo Group Ltd |
Protivnetni 17.beta-karbotioatestrski derivati androstana s ciklično estrsko skupino na položaju 17.alfa
|
EP1258247A1
(en)
|
2001-05-14 |
2002-11-20 |
Aventis Pharma Deutschland GmbH |
Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
|
ES2307751T3
(es)
|
2001-06-12 |
2008-12-01 |
Glaxo Group Limited |
Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano.
|
EP2327765B1
(en)
|
2001-06-21 |
2015-04-01 |
BASF Enzymes LLC |
Nitrilases
|
PL393155A1
(pl)
|
2001-09-14 |
2011-03-28 |
Glaxo Group Limited |
Pochodne fenetanoloaminy do leczenia chorób układu oddechowego
|
US7361668B2
(en)
|
2001-10-17 |
2008-04-22 |
Ucb, S.A. |
Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
AR037517A1
(es)
|
2001-11-05 |
2004-11-17 |
Novartis Ag |
Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
US6653323B2
(en)
|
2001-11-13 |
2003-11-25 |
Theravance, Inc. |
Aryl aniline β2 adrenergic receptor agonists
|
AU2002356759A1
(en)
|
2001-12-01 |
2003-06-17 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
CN1832948B
(zh)
|
2001-12-20 |
2011-06-15 |
基耶西药品股份公司 |
1-烷基-1-氮*双环[2.2.2]辛烷氨基甲酸酯衍生物及其用作蕈毒碱受体拮抗剂的用途
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
WO2003062259A2
(en)
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
US7414036B2
(en)
|
2002-01-25 |
2008-08-19 |
Muscagen Limited |
Compounds useful as A3 adenosine receptor agonists
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
WO2003082787A1
(en)
|
2002-03-26 |
2003-10-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ES2298508T3
(es)
|
2002-03-26 |
2008-05-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos.
|
JP2006515829A
(ja)
|
2002-04-10 |
2006-06-08 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
炎症性疾病の処置のための、a2aアデノシン受容体アゴニストの使用
|
DE60335869D1
(de)
|
2002-04-11 |
2011-03-10 |
Merck Sharp & Dohme |
1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
ES2298511T3
(es)
|
2002-04-25 |
2008-05-16 |
Glaxo Group Limited |
Derivados de fenetanolamina.
|
EP1507754A1
(en)
|
2002-05-28 |
2005-02-23 |
Theravance, Inc. |
Alkoxy aryl beta-2 adrenergic receptor agonists
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
DE60312520T2
(de)
|
2002-06-25 |
2007-11-22 |
Merck Frosst Canada Ltd., Kirkland |
8-(biaryl)chinolin-pde4-inhibitoren
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
WO2004005258A1
(en)
|
2002-07-02 |
2004-01-15 |
Merck Frosst Canada & Co. |
Di-aryl-substituted-ethane pyridone pde4 inhibitors
|
PT1521733E
(pt)
|
2002-07-08 |
2014-10-29 |
Pfizer Prod Inc |
Moduladores do recetor de glucocorticoides
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR040962A1
(es)
|
2002-08-09 |
2005-04-27 |
Novartis Ag |
Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
|
US20060167001A1
(en)
|
2002-08-10 |
2006-07-27 |
Sterk Jan G |
Pyridazinone-derivatives as pde4 inhibitors
|
AU2003255376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
JP4555684B2
(ja)
|
2002-08-10 |
2010-10-06 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Pde4阻害剤としての、ピロリジンジオンにより置換されたピペリジン−フタラゾン
|
CA2494643A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Piperidine-n-oxide-derivatives
|
PL373598A1
(en)
|
2002-08-17 |
2005-09-05 |
Altana Pharma Ag |
Novel benzonaphthyridines
|
US20060116518A1
(en)
|
2002-08-17 |
2006-06-01 |
Altana Pharma Ag |
Novel phenanthridines
|
EP1532113B1
(en)
|
2002-08-21 |
2008-08-06 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
EP1534675B1
(en)
|
2002-08-23 |
2009-02-25 |
Ranbaxy Laboratories, Ltd. |
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
|
KR20050036982A
(ko)
|
2002-08-29 |
2005-04-20 |
베링거 인겔하임 파마슈티칼즈, 인코포레이티드 |
염증, 알러지 및 증식성 질환의 치료에 글루코코르티코이드모사체로 사용하기 위한 3-(설폰아미도에틸)-인돌 유도체
|
ES2281658T3
(es)
|
2002-08-29 |
2007-10-01 |
Nycomed Gmbh |
3-hidroxi-6-fenilfenantridinas como inhibidores de pde-4.
|
WO2004019944A1
(en)
|
2002-08-29 |
2004-03-11 |
Altana Pharma Ag |
2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
CN1688577A
(zh)
|
2002-09-18 |
2005-10-26 |
小野药品工业株式会社 |
三氮杂螺[5.5]十一烷衍生物及以它为活性成分的药物
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
WO2004026248A2
(en)
|
2002-09-20 |
2004-04-01 |
Merck & Co., Inc. |
Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
KR20050047552A
(ko)
|
2002-10-11 |
2005-05-20 |
화이자 인코포레이티드 |
베타-2 작용제로서의 인돌 유도체
|
EP1440966A1
(en)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Indole derivatives useful for the treatment of diseases
|
US20060205790A1
(en)
|
2002-10-22 |
2006-09-14 |
Coe Diane M |
Medicinal arylethanolamine compounds
|
EP1554262B1
(en)
|
2002-10-23 |
2007-12-05 |
Glenmark Pharmaceuticals Limited |
Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
|
PL377122A1
(pl)
|
2002-10-28 |
2006-01-23 |
Glaxo Group Limited |
Pochodne fenetanoloaminy do leczenia chorób układu oddechowego
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225287D0
(en)
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10261874A1
(de)
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
AU2004207482B2
(en)
|
2003-01-21 |
2009-10-08 |
Merck Sharp & Dohme Corp. |
17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
EP1615881A2
(en)
|
2003-04-01 |
2006-01-18 |
Theravance, Inc. |
Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
|
AU2004226824B2
(en)
|
2003-04-04 |
2008-05-01 |
Novartis Ag |
Quinoline-2-one-derivatives for the treatment of airways diseases
|
US7268147B2
(en)
|
2003-05-15 |
2007-09-11 |
Pfizer Inc |
Compounds useful for the treatment of diseases
|
US7358244B2
(en)
|
2003-05-28 |
2008-04-15 |
Theravance, Inc. |
Azabicycloalkane compounds
|
MXPA05013059A
(es)
|
2003-06-04 |
2006-03-02 |
Pfizer |
Derivados de 2-amino-piridina como agonistas del adrenoceptor beta-2.
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
DE10332239B3
(de)
|
2003-07-16 |
2005-03-03 |
Framatome Anp Gmbh |
Zirkoniumlegierung und Bauteile für den Kern von leichtwassergekühlten Kernreaktoren
|
WO2005033121A2
(en)
|
2003-10-03 |
2005-04-14 |
King Pharmaceuticals Research & Development, Inc. |
Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
|
GB0323701D0
(en)
|
2003-10-09 |
2003-11-12 |
Glaxo Group Ltd |
Formulations
|
GB0324654D0
(en)
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US7591941B2
(en)
|
2003-12-19 |
2009-09-22 |
Shell Oil Company |
Systems, methods, and catalysts for producing a crude product
|
JP2007517019A
(ja)
|
2003-12-29 |
2007-06-28 |
カン−フィテ・バイオファーマ・リミテッド |
多発性硬化症の治療方法
|
DE102004001413A1
(de)
|
2004-01-09 |
2005-08-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DK1708992T3
(da)
|
2004-01-22 |
2007-11-05 |
Pfizer |
Sulfonamidderivater til behandling af sygdomme
|
GEP20094781B
(en)
|
2004-01-22 |
2009-09-25 |
Pfizer |
Sulfonamide derivatives for the treatment of diseases
|
US7320990B2
(en)
|
2004-02-13 |
2008-01-22 |
Theravance, Inc. |
Crystalline form of a biphenyl compound
|
CA2552871A1
(en)
|
2004-02-14 |
2005-08-25 |
Boehringer Ingelheim International Gmbh |
Novel, sustained-action beta-2-agonists and their use as medicaments
|
EP1749016A2
(en)
|
2004-03-05 |
2007-02-07 |
Cambridge Biotechnology Ltd |
Adenosine receptor agonists
|
JP2007536241A
(ja)
|
2004-05-03 |
2007-12-13 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
糖尿病性腎症の処置のためのa2aアデノシンレセプターアゴニスト
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
PL1778239T3
(pl)
|
2004-07-28 |
2014-01-31 |
Can Fite Biopharma Ltd |
Agoniści receptora adenozynowego A3 do leczenia zaburzeń suchego oka w tym zespołu Sjogrena
|
US7825102B2
(en)
|
2004-07-28 |
2010-11-02 |
Can-Fite Biopharma Ltd. |
Treatment of dry eye conditions
|
WO2006031505A1
(en)
|
2004-09-09 |
2006-03-23 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Purine derivatives as a3 and a1 adenosine receptor agonists
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
US20080051364A1
(en)
|
2004-11-08 |
2008-02-28 |
Pninna Fishman |
Therapeutic Treatment of Accelerated Bone Resorption
|
GB0500785D0
(en)
*
|
2005-01-14 |
2005-02-23 |
Novartis Ag |
Organic compounds
|
RS52458B
(en)
*
|
2005-02-04 |
2013-02-28 |
Millennium Pharmaceuticals Inc. |
E1 ENZYMING ENZYME INHIBITORS
|
GB0505219D0
(en)
|
2005-03-14 |
2005-04-20 |
Novartis Ag |
Organic compounds
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
AU2006321165B2
(en)
|
2005-11-30 |
2010-04-22 |
Can-Fite Biopharma Ltd. |
Use of A3 adenosine receptor agonist in osteoarthritis treatment
|
DK1983990T3
(da)
|
2006-01-26 |
2011-07-11 |
Us Gov Health & Human Serv |
Allosteriske A3-adenosin-receptormodulatorer
|
CA2639924C
(en)
*
|
2006-02-02 |
2017-01-10 |
Millennium Pharmaceuticals, Inc. |
Purinyl-and pyrrolo[2,3-d]pyrimidinyl cyclopentyl compounds and their use as inhibitors of e1 activating enzymes
|
WO2007092936A2
(en)
|
2006-02-08 |
2007-08-16 |
University Of Virginia Patent Foundation |
Method to treat gastric lesions
|
GB0607951D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607954D0
(en)
*
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607944D0
(en)
*
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607945D0
(en)
*
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
PT2322525E
(pt)
|
2006-04-21 |
2013-12-26 |
Novartis Ag |
Derivados de purina para utilização como agonistas do recetor de adenosina a2a
|
GB0607948D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607953D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607950D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
EP1889846A1
(en)
|
2006-07-13 |
2008-02-20 |
Novartis AG |
Purine derivatives as A2a agonists
|
US8008307B2
(en)
*
|
2006-08-08 |
2011-08-30 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
|
EP1903044A1
(en)
|
2006-09-14 |
2008-03-26 |
Novartis AG |
Adenosine Derivatives as A2A Receptor Agonists
|
CA2669108A1
(en)
|
2006-11-10 |
2008-05-15 |
Novartis Ag |
Cyclopentene diol monoacetate derivatives
|
WO2008124150A1
(en)
|
2007-04-09 |
2008-10-16 |
University Of Virginia Patent Foundation |
Method of treating enteritis, intestinal damage, and diarrhea from c. difficile with an a2a adenosine receptor agonist
|
US20080262001A1
(en)
|
2007-04-23 |
2008-10-23 |
Adenosine Therapeutics, Llc |
Agonists of a2a adenosine receptors for treating recurrent tumor growth in the liver following resection
|
US8153781B2
(en)
|
2007-06-29 |
2012-04-10 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Dendrimer conjugates of agonists and antagonists of the GPCR superfamily
|
KR20100068286A
(ko)
|
2007-10-17 |
2010-06-22 |
노파르티스 아게 |
아데노신 a1 수용체 리간드로서의 퓨린 유도체
|
US20090181934A1
(en)
*
|
2007-10-17 |
2009-07-16 |
Novartis Ag |
Organic Compounds
|
WO2009061516A1
(en)
|
2007-11-08 |
2009-05-14 |
New York University School Of Medicine |
Medical implants containing adenosine receptor agonists and methods for inhibiting medical implant loosening
|
CN101938904A
(zh)
|
2008-01-09 |
2011-01-05 |
PGx健康有限责任公司 |
用a2ar激动剂鞘内治疗神经性疼痛
|